These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 16013491)

  • 21. Effects of site-specific polyethylene glycol modification of recombinant human granulocyte colony-stimulating factor on its biologic activities.
    Hao Y; Chen J; Wang X; Zhu H; Rong Z
    BioDrugs; 2006; 20(6):357-62. PubMed ID: 17176123
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Analytical and preparative separation of PEGylated lysozyme for the characterization of chromatography media.
    Moosmann A; Christel J; Boettinger H; Mueller E
    J Chromatogr A; 2010 Jan; 1217(2):209-15. PubMed ID: 19963219
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Construction of a Pichia pastoris strain efficiently producing recombinant human granulocyte-colony stimulating factor (rhG-CSF) and study of its biological activity on bone marrow cells.
    Pykhtina MB; Romanov VP; Miroshnichenko SM; Beklemishev AB
    Mol Biol Rep; 2020 Jan; 47(1):607-620. PubMed ID: 31713007
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmacokinetics and safety of pegylated recombinant human granulocyte colony-stimulating factor in children with acute leukaemia.
    Liu XT; Zhao YX; Jia GW; Yang F; Zhang CZ; Han B; Dai JH; Han YQ; Tang BH; Yang XM; Shi HY; Zhou Y; Sui ZG; Chen JZ; van den Anker JN; Zhao W
    Br J Clin Pharmacol; 2021 Aug; 87(8):3292-3300. PubMed ID: 33506975
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Pharmacokinetics of PEG-rhG-CSF and rHSA-hG-CSF in mice determined with ELISA].
    Ma GC; Chen SQ; Zhu ZH; Huang YS; Pan HQ; Zhou JB
    Yao Xue Xue Bao; 2007 Feb; 42(2):197-200. PubMed ID: 17518051
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Renaturation with simultaneous purification of rhG-CSF from Escherichia coli by ion exchange chromatography.
    Wang C; Wang L; Geng X
    Biomed Chromatogr; 2007 Dec; 21(12):1291-6. PubMed ID: 17634960
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Anaphylaxis caused by pegylated recombinant human granulocyte colony-stimulating factor.
    Chen C; Qi J; Wang J
    J Oncol Pharm Pract; 2023 Apr; 29(3):727-730. PubMed ID: 35833225
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Site-specific conjugation of diethylenetriaminepentaacetic acid to recombinant human granulocyte-colony-stimulating factor: preservation of protein structure and function.
    Ralph LD; Ransone CM; Treuheit M; Lauren S; Katta V; Litzinger DC
    Biochemistry; 1995 Apr; 34(14):4889-97. PubMed ID: 7536471
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Expression and purification of recombinant human granulocyte colony-stimulating factor in fed-batch culture of Escherichia coli.
    Kim CK; Choi JH; Lee SB; Lee SM; Oh JW
    Appl Biochem Biotechnol; 2014 Mar; 172(5):2425-35. PubMed ID: 24390866
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Synergistic effects of pegylated recombinant human megakaryocyte growth and development factor and granulocyte colony-stimulating factor on mobilization of hematopoietic progenitor and stem cells with long-term repopulating ability into peripheral blood in mice.
    Honda K; Takenaka K; Shinagawa K; Ishimaru F; Ikeda K; Niiya K; Harada M
    Bone Marrow Transplant; 2001 Aug; 28(4):329-34. PubMed ID: 11571503
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Purification and characterization of recombinant human granulocyte colony-stimulating factor (rhG-CSF) derivatives: KW-2228 and other derivatives.
    Yamasaki M; Konishi N; Yamaguchi K; Itoh S; Yokoo Y
    Biosci Biotechnol Biochem; 1998 Aug; 62(8):1528-34. PubMed ID: 9757559
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacokinetics of recombinant human granulocyte colony-stimulating factor conjugated to polyethylene glycol in rats.
    Tanaka H; Satake-Ishikawa R; Ishikawa M; Matsuki S; Asano K
    Cancer Res; 1991 Jul; 51(14):3710-4. PubMed ID: 1712246
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mutation of surface-exposed histidine residues of recombinant human granulocyte-colony stimulating factor (Cys17Ser) impacts on interaction with chelated metal ions and refolding in aqueous two-phase systems.
    Zaveckas M; Luksa V; Zvirblis G; Chmieliauskaite V; Bumelis V; Pesliakas H
    J Chromatogr B Analyt Technol Biomed Life Sci; 2003 Mar; 786(1-2):17-32. PubMed ID: 12650998
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Improved process for production of recombinant yeast-derived monomeric human G-CSF.
    Bae CS; Yang DS; Lee J; Park YH
    Appl Microbiol Biotechnol; 1999 Sep; 52(3):338-44. PubMed ID: 10531646
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prolonged circulation of recombinant human granulocyte-colony stimulating factor by covalent linkage to albumin through a heterobifunctional polyethylene glycol.
    Paige AG; Whitcomb KL; Liu J; Kinstler O
    Pharm Res; 1995 Dec; 12(12):1883-8. PubMed ID: 8786961
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Capillary electrophoretic separation of poly(ethylene glycol)-modified granulocyte-colony stimulating factor.
    Lee KS; Na DH
    Arch Pharm Res; 2010 Mar; 33(3):491-5. PubMed ID: 20361316
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Purification of PEGylated protein using membrane chromatography.
    Yu D; Ghosh R
    J Pharm Sci; 2010 Aug; 99(8):3326-33. PubMed ID: 20186937
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Refolding and purification of recombinant human granulocyte colony-stimulating factor from Escherichia coli by using protein folding liquid chromatography].
    Wang C; Wang L; Geng X
    Se Pu; 2007 Jul; 25(4):514-7. PubMed ID: 17970109
    [TBL] [Abstract][Full Text] [Related]  

  • 39. High recovery refolding of rhG-CSF from Escherichia coli, using urea gradient size exclusion chromatography.
    Wang C; Wang L; Geng X
    Biotechnol Prog; 2008; 24(1):209-13. PubMed ID: 18179225
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [A multicenter, randomized, controlled, phase Ⅳ clinical study of PEG-rhG-CSF for preventing chemotherapy induced neutropenia in patients with breast cancer].
    Jiang ZF; Xu FR; Fan J; Li BJ; Gao JN; Hu JW; Wang XJ; Zhang YQ; Wang JH; Li F; Liu Q; Liu YH; Wang S; Wang YS; Ouyang QC; Hu B; Sun GP; Zhang Y; Zang AM; Fan PZ; Wu CP; Liu J; Zhang HW; Wang W; Hu XC; Tang LL; Zhang J; Bao YY; Geng CZ; Sun Q; Zhang F; Yin YM; Jiang HC; An YH
    Zhonghua Yi Xue Za Zhi; 2018 Apr; 98(16):1231-1235. PubMed ID: 29747310
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.